PubMed=21356356; DOI=10.1016/j.ajpath.2010.12.014; PMCID=PMC3070574
Gueugnon F., Leclercq S., Blanquart C., Sagan C., Cellerin L., Padieu M., Perigaud C., Scherpereel A., Gregoire M.
Identification of novel markers for the diagnosis of malignant pleural mesothelioma.
Am. J. Pathol. 178:1033-1042(2011)

PubMed=21540305; DOI=10.1183/09031936.00160210
Roulois D., Vignard V., Gueugnon F., Labarriere N., Gregoire M., Fonteneau J.-F.
Recognition of pleural mesothelioma by mucin-1(950-958)/human leukocyte antigen A*0201-specific CD8+ T-cells.
Eur. Respir. J. 38:1117-1126(2011)

PubMed=21774103; DOI=10.1097/JTO.0b013e318215a07d
Brevet M., Shimizu S., Bott M.J., Shukla N., Zhou Q., Olshen A.B., Rusch V.W., Ladanyi M.
Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy.
J. Thorac. Oncol. 6:864-874(2011)

PubMed=22144115; DOI=10.1002/eji.201141800
Roulois D., Blanquart C., Panterne C., Gueugnon F., Gregoire M., Fonteneau J.-F.
Downregulation of MUC1 expression and its recognition by CD8(+) T cells on the surface of malignant pleural mesothelioma cells treated with HDACi.
Eur. J. Immunol. 42:783-789(2012)

PubMed=26539644; DOI=10.18632/oncotarget.6285; PMCID=PMC4792599
Achard C., Boisgerault N., Delaunay T., Roulois D., Nedellec S., Royer P.-J., Pain M., Combredet C., Mesel-Lemoine M., Cellerin L., Magnan A., Tangy F., Gregoire M., Fonteneau J.-F.
Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response.
Oncotarget 6:44892-44904(2015)